BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7155993)

  • 21. Exchange assay for androgen receptors in the presence of molybdate.
    Carroll SL; Rowley DR; Chang CH; Tindall DJ
    J Steroid Biochem; 1984 Oct; 21(4):353-9. PubMed ID: 6387280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Measurement of androgen receptor in cytosols from normal, benign hypertrophic and cancerous human prostates.
    Shimazaki J; Hikage T; Sato R; Kodama T; Ito H
    Endocrinol Jpn; 1981 Dec; 28(6):725-34. PubMed ID: 6179768
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Conversion from 4S androgen receptor from rat submandibular gland to higher molecular form and the effect of sodium molybdate.
    Ohara-Nemoto Y; Nemoto T; Ota M
    J Steroid Biochem; 1985 Nov; 23(5A):643-9. PubMed ID: 4079380
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molybdate and the 1,25-dihydroxyvitamin D3 receptor from chick intestine.
    Nakada M; Simpson RU; DeLuca HF
    Arch Biochem Biophys; 1985 May; 238(2):517-21. PubMed ID: 2986552
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molybdate effect on the glucocorticoid receptor in cell-free systems and intact lymphocytes.
    NĂ¡ray A
    Biochim Biophys Acta; 1983 Apr; 756(3):328-34. PubMed ID: 6830858
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential effects of molybdate on the hydrodynamic and DNA-binding properties of the non-activated and activated forms of the androgen receptor in calf uterus.
    de Boer W; Bolt J; Brinkmann AO; Mulder E
    Biochim Biophys Acta; 1986 Nov; 889(2):240-50. PubMed ID: 3778950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pyridoxal phosphate blocks aggregation of molybdate treated glucocorticoid receptors in HeLa S3 cells.
    Cidlowski JA; Currie RA
    J Steroid Biochem; 1982 Sep; 17(3):277-80. PubMed ID: 7132345
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methods for the determination of androgen receptor content in human prostatic tissue.
    Trachtenberg J; Hicks LL; Walsh PC
    Invest Urol; 1981 Mar; 18(5):349-54. PubMed ID: 7203958
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Androgen regulation of androgen receptor content and distribution in the ventral and dorsolateral prostates of aging AXC rats.
    Boesel RW; Klipper RW; Shain SA
    Steroids; 1980 Feb; 35(2):157-77. PubMed ID: 7376216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen regulation of rat prostate androgen receptor.
    Bouton MM; Pornin C; Grandadam JA
    J Steroid Biochem; 1981 Dec; 15():403-8. PubMed ID: 7339268
    [No Abstract]   [Full Text] [Related]  

  • 32. Subcellular distribution of androgen receptors in human normal, benign hyperplastic, and malignant prostatic tissues: characterization of nuclear salt-resistant receptors.
    Barrack ER; Bujnovszky P; Walsh PC
    Cancer Res; 1983 Mar; 43(3):1107-16. PubMed ID: 6186370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New observation on androgen action: androgen receptor stabilization and antisteroid effects of LHRH agonists.
    Wright W; Chan K; Sundaram K; Bardin CW
    Adv Exp Med Biol; 1981; 138():325-36. PubMed ID: 7044055
    [No Abstract]   [Full Text] [Related]  

  • 34. [The antiandrogen effect of gossypol and its influence on androgen receptor].
    Li FY; Wang NG; Lei HP
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1985 Feb; 7(1):53-4. PubMed ID: 3158419
    [No Abstract]   [Full Text] [Related]  

  • 35. Application of high-performance liquid chromatofocusing to the study of prostatic androgen receptors. Effect of stabilizing agents on the heterogeneity of receptor structure.
    Bouthillier F; Carmel M; Elhilali M; Radwan F; Lehoux JG
    J Chromatogr; 1987 Aug; 403():171-82. PubMed ID: 3680407
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Low molecular weight component of androgen receptor in cytosols from benign hypertrophic human prostate treated with high KCl solution.
    Kodama T; Fuse H; Shimazaki J
    Endocrinol Jpn; 1982 Jun; 29(3):325-33. PubMed ID: 6184218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of androgen-receptor interaction in mouse prostate gland cytosol by divalent metal ions.
    Donovan MP; Schein LG; Thomas JA
    Mol Pharmacol; 1980 Mar; 17(2):156-62. PubMed ID: 7393202
    [No Abstract]   [Full Text] [Related]  

  • 38. [Studies of progestin specific binding protein in the human prostate. [III]; Sodium molybdate effect on SDG analysis].
    Imai K; Kumasaka F; Kobayashi M; Takahashi Y; Takahashi E; Yamanaka H
    Nihon Naibunpi Gakkai Zasshi; 1985 Aug; 61(8):816-22. PubMed ID: 2416602
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inactivation of rat liver glucocorticoid receptor by molybdate. Effects on both non-activated and activated receptor complexes.
    Murakami N; Moudgil VK
    Biochem J; 1981 Sep; 198(3):447-55. PubMed ID: 6275847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of the nuclear dihydrotestosterone receptor complex from rat ventral prostate by antiandrogens and stilboestrol.
    Smith CB; Ghanadian R; Chisholm GD
    Mol Cell Endocrinol; 1978; 10(1):13-20. PubMed ID: 75813
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.